Cyclin C Antibody [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-18878V
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Chicken (100%), Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry, Immunoprecipitation
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 244 and 294 of human cyclin C using the numbering given in entry NP_005181.2 (GeneID 892).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Cyclin C Antibody [DyLight 405]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cyclin C
Alternate Names
CycC, cyclin C, cyclin-C, hSRB11, SRB11 homolog
Gene Symbol
CCNC
Additional Cyclin C Products
Product Documents for Cyclin C Antibody [DyLight 405]
Product Specific Notices for Cyclin C Antibody [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...